Edition:
United States

Second Sight Medical Products Inc (EYES.OQ)

EYES.OQ on NASDAQ Stock Exchange Capital Market

2.18USD
3:59pm EST
Change (% chg)

$-0.17 (-7.23%)
Prev Close
$2.35
Open
$2.35
Day's High
$2.48
Day's Low
$2.08
Volume
281,364
Avg. Vol
85,818
52-wk High
$2.82
52-wk Low
$0.90

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Robert Greenberg

49 2015 Chairman of the Board

Jonathan McGuire

54 2015 President, Chief Executive Officer, Director

Frank Vandeputte

2017 Vice President, General Manager

Gregoire Cosendai

45 2017 Vice President - Clinical Affairs

Stephen Okland

53 2016 Commercial Vice President, U.S. and Canada